Your browser doesn't support javascript.
loading
Treatment of metastatic extramammary Paget's disease associated with adnexal adenocarcinoma, with anti-HER2 drugs based on genomic alteration ERBB2 S310F.
Vornicova, Olga; Hershkovitz, Dov; Yablonski-Peretz, Tamar; Ben-Itzhak, Ofer; Keidar, Zohar; Bar-Sela, Gil.
Afiliação
  • Vornicova O; Division of Oncology, Rambam Health Care Campus and Technion-Israel Institute of Technology, Haifa, Israel.
  • Hershkovitz D; Institute of Pathology, Rambam Health Care Campus and Technion-Israel Institute of Technology, Haifa, Israel.
  • Yablonski-Peretz T; Sharett Institute of Oncology, Hadassah Medical Center, Hebrew University, Jerusalem, Israel.
  • Ben-Itzhak O; Institute of Pathology, Rambam Health Care Campus and Technion-Israel Institute of Technology, Haifa, Israel.
  • Keidar Z; Department of Nuclear Medicine, Rambam Health Care Campus and Technion-Israel Institute of Technology, Haifa, Israel.
  • Bar-Sela G; Division of Oncology, Rambam Health Care Campus and Technion-Israel Institute of Technology, Haifa, Israel.
Oncologist ; 19(9): 1006-7, 2014 Sep.
Article em En | MEDLINE | ID: mdl-25085898
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Doenças dos Anexos / Doença de Paget Extramamária / Receptor ErbB-2 Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Doenças dos Anexos / Doença de Paget Extramamária / Receptor ErbB-2 Idioma: En Ano de publicação: 2014 Tipo de documento: Article